Primary mediastinal large B-cell lymphoma: Optimal therapy and prognostic factors in 41 consecutive Asian patients

Leukemia and Lymphoma

Volumn 52, Issue 4, 2011, Pages 604-612

  Tai, Wai Meng ^a   Quah, Daniel ^a   Peng Yap, Swee ^a   Huey Tan, Sze ^a   Tang, Tiffany ^a   Tay, Kuang Wei ^a   Koo, Yu Xuan ^a   Tao, Miriam ^a   Quek, Richard ^a   Lim, Soon Thye ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

asian patients; mediastinal radiotherapy; Primary mediastinal B cell lymphoma; prognostic factors; rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 79953189424     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.550073     Document Type: Article

References (16)

1. Savage KJ, Al-Rajhi N, Voss N, et al. Favorable outcome of primary mediastinal large B cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006;17:123-130. (Pubitemid 43033851)
2. Hamlin PA, Portlock CS, Straus DJ, et al. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. BrJHematol 2005;130:691-699.
3. Todeschini G, Secchi S, Morra E, et al. Primary mediastinal large B cell lymphoma: long term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 2004;90:372-376. (Pubitemid 38250631)
4. Haioun C, Gaulard P, Roudot-Thoraval F, et al. Mediastinal diffuse large B cell lymphoma with sclerosis: a condition with poor prognosis. Am J Clin Oncol 1989;12:425-429. (Pubitemid 19251392)
5. Todeschini G, Ambrosetti A, Meneghini V, et al. Mediastinal large B cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 1990;8:804-808. (Pubitemid 20148271)
6. Kim D, Mauch P, Shaffer K, et al. Large cell immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993;11: 1336-1343. (Pubitemid 23199139)
7. Zinzani PL, Martelli M, Bertini M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymophoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Hematologica 2002;87: 1258-1264. (Pubitemid 36005300)
8. Rodriguez J, Conde E, Gutierrez A, et al. Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GELTA-MO experience. Hematol Oncol 2008;26:171-178.
9. Abou-Elella AA, Weisenburger DD, Armitage JO, et al. Primary mediastinal large B-cell lymphoma: a clinicopatholo-gic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol 1999;17:784-790. (Pubitemid 29109306)
10. Pfreundschuh M, SchubertJ, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ Bcell lymphomas: a randomized controlled trial (RICOVER-60). Lancet Oncol 2008;9:105-116.
11. Feugier P, Van Hoof A, Sebban C, et al. Long term results of the R-CHOP study in treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymhomes de l'Adulte. J Clin Oncol 2005;23: 4117-4126. (Pubitemid 46211317)
12. Coiffer B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002;346:235-242. (Pubitemid 34438862)
13. Lazzarino M, Orlandi E, Paulli E, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B cell lymphoma: a multi centre study of 106 patients. J Clin Oncol 1997;15:1646-1653. (Pubitemid 27167405)
14. Han HS, Escalo MP, Hsiao B, et al. High incidence of false positive PET scans in patients with aggressive non Hodgkin lymphoma treated with rituximab containing regimen. Ann Oncol 2010;20:309-318.
15. Horning SJ, Juweid ME, Schoder H, et al. Interim positron emission tomography scans in diffuse large B cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood 2010;115:775-777.
16. The International Non Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-hodgkin lymphoma. N Engl J Med 1993;329:987-994.